HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Johnson, J. L. Articles by Sheffield, L. G. Search for Related Content PubMed PubMed Citation Articles by Johnson, J. L. Articles by Sheffield, L. G. Social Bookmarking                      What's this?

Volume 271, Number 35, Issue of August 30, 1996 pp. 21574-21578
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Prolactin Inhibits Epidermal Growth Factor-induced Ras-MAPK Signaling in Mammary Epithelial Cells

(Received for publication, December 11, 1995, and in revised form, May 21, 1996)

From the Endocrinology-Reproductive Physiology Program, University of Wisconsin, Madison, Wisconsin 53706

Previously, our laboratory has shown that prolactin (PRL) inhibits epidermal growth factor (EGF)-induced DNA synthesis. One pathway for the initiation of DNA synthesis is EGF-receptor (EGF-R) signaling through Ras and mitogen-activated protein kinase (MAPK). To determine the effects of PRL on EGF-induced MAPK activation and phosphorylation, MAPK or phosphotyrosine (Tyr(P)) was immunoprecipitated from normal murine mammary epithelial (NMuMG) cells treated with PRL (100 ng/ml) and/or EGF (10 ng/ml) for 10-min periods. EGF-induced phosphorylation and activation were then examined by Western analysis and a myelin basic protein (MBP)-specific kinase assay. The p42 isoform of MAPK showed a distinct decrease in activity and phosphorylation when cells were treated with PRL. Concluding that PRL affects EGF signaling upstream of MAPK, we examined the effect of PRL on EGF-induced Ras activity. NMuMG cells were incubated with [³²P]orthophosphoric acid, treated as described above, immunoprecipitated with an antibody specific to Ras, and nucleotides were eluted and separated by TLC. Ras activity as measured by GTP:GDP ratio was increased by EGF, but not by PRL. Additionally, PRL in combination with EGF abolished the ability of EGF to induce Ras activity. Those studies suggest that PRL alters the EGF signaling pathway upstream of Ras. Because Ras activation by EGF involves EGF-stimulated association of EGF-R with Grb2, the EGF-R was immunoprecipitated and a Western blot was probed for Grb2. As expected we found that EGF stimulated an association of EGF-R with Grb2, PRL, however, blocked this association. When we looked at the ability of Shc to associate with the EGF-R, we found that PRL and EGF had little effect on this association. The studies demonstrate that PRL either directly or indirectly inhibits the ability of EGF to induce EGF-R association with Grb2, to activate Ras, and to activate and phosphorylate MAPK.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. S. Muraoka-Cook, M. Sandahl, D. Hunter, L. Miraglia, and H. S. Earp III Prolactin and ErbB4/HER4 Signaling Interact via Janus Kinase 2 to Induce Mammary Epithelial Cell Gene Expression Differentiation Mol. Endocrinol., October 1, 2008; 22(10): 2307 - 2321. [Abstract] [Full Text] [PDF]

				S. K. Halder, G. Anumanthan, R. Maddula, J. Mann, A. Chytil, A. L. Gonzalez, M. K. Washington, H. L. Moses, R. D. Beauchamp, and P. K. Datta Oncogenic Function of a Novel WD-Domain Protein, STRAP, in Human Carcinogenesis. Cancer Res., June 15, 2006; 66(12): 6156 - 6166. [Abstract] [Full Text] [PDF]

				L. M. Arendt, T. A. Rose-Hellekant, E. P. Sandgren, and L. A. Schuler Prolactin Potentiates Transforming Growth Factor {alpha} Induction of Mammary Neoplasia in Transgenic Mice Am. J. Pathol., April 1, 2006; 168(4): 1365 - 1374. [Abstract] [Full Text] [PDF]

				L. G. Sheffield and J. J. Gavinski Proteomics Methods for Probing Molecular Mechanisms in Signal Transduction J Dairy Sci, July 1, 2003; 86(13_suppl): E115 - 124. [Abstract] [Full Text] [PDF]

				L. G. Sheffield and J. J. Gavinski Proteomics methods for probing molecular mechanisms in signal transduction J Anim Sci, March 1, 2003; 81(suppl_3): 48 - 57. [Abstract] [Full Text] [PDF]

				J. K. G. Crean, D. Finlay, M. Murphy, C. Moss, C. Godson, F. Martin, and H. R. Brady The Role of p42/44 MAPK and Protein Kinase B in Connective Tissue Growth Factor Induced Extracellular Matrix Protein Production, Cell Migration, and Actin Cytoskeletal Rearrangement in Human Mesangial Cells J. Biol. Chem., November 8, 2002; 277(46): 44187 - 44194. [Abstract] [Full Text] [PDF]

				K. L. Schwertfeger, S. Hunter, L. E. Heasley, V. Levresse, R. P. Leon, J. DeGregori, and S. M. Anderson Prolactin Stimulates Activation of c-jun N-Terminal Kinase (JNK) Mol. Endocrinol., October 1, 2000; 14(10): 1592 - 1602. [Abstract] [Full Text]

				J. Boerner, M. McManus, G. Martin, and N. Maihle Ras-independent oncogenic transformation by an EGF-receptor mutant J. Cell Sci., January 3, 2000; 113(6): 935 - 942. [Abstract] [PDF]

				V. J. Quijano Jr. and L. G. Sheffield Prolactin Decreases Epidermal Growth Factor Receptor Kinase Activity via a Phosphorylation-dependent Mechanism J. Biol. Chem., January 9, 1998; 273(2): 1200 - 1207. [Abstract] [Full Text] [PDF]

				Y. Cheng, I. Zhizhin, R. L. Perlman, and D. Mangoura Prolactin-induced Cell Proliferation in PC12 Cells Depends on JNK but Not ERK Activation J. Biol. Chem., July 21, 2000; 275(30): 23326 - 23332. [Abstract] [Full Text] [PDF]

				J. L. Boerner, A. Danielsen, M. J. McManus, and N. J. Maihle Activation of Rho Is Required for Ligand-independent Oncogenic Signaling by a Mutant Epidermal Growth Factor Receptor J. Biol. Chem., January 26, 2001; 276(5): 3691 - 3695. [Abstract] [Full Text] [PDF]